FierceBiotech

Dream come true: Owlet soars to FDA nod for over-the-counter infant pulse oximeter

Owlet is surely flying high after finally securing FDA clearance for its Dream Sock baby monitoring system that alerts parents and other caregivers if a child’s vital signs leave healthy ranges—a ...
Morningstar

Owlet Announces New DME Partnership With 1 Natural Way to Expand Insurance-Supported Access to BabySat® Infant Pulse Oximeter

Collaboration expands Owlet’s national DME footprint, strengthens access for Medicaid and TRICARE families, and supports continued growth in prescription-backed revenue channel. Families nationwide ...
Monthly Prescribing Reference

FDA Clears BabySat, an At-Home Pulse Oximetry Sock Device for Infants

Credit: Owlet. BabySat is expected to be available by prescription later this year. The Food and Drug Administration (FDA) has cleared BabySat ™, a prescription pulse oximetry device for infants that ...
Business Wire

Owlet Announces FDA-Clearance of the First Prescription Pulse Oximetry Sock for Infants

LEHI, Utah--(BUSINESS WIRE)--Owlet (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, announces clearance from the U.S. Food and Drug Administration (“FDA”) of BabySat™, the first ...
BMJ Global Health

A pilot implementation study to detect neonatal critical congenital heart disease using pulse oximetry screening in Accra, Ghana

Background Congenital heart disease (CHD) is the leading congenital cause of death in newborns worldwide. Approximately ...